Suchergebnisse - "Rigo, Fabio"

PubPharm (19)

1

Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression : a prospective cohort study

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2022

von Savoldi, A. | Morra, M. | De Nardo, P. | +31

2

Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART

enthalten in: Frontiers in endocrinology | 2019

von Dalla Grana, E. | Rigo, F. | Lanzafame, M. | +5

3

Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities

enthalten in: BMC infectious diseases | 2018

von Marcus, U. | Nöstlinger, C. | Rosińska, M. | +110

4

Dolutegravir monotherapy in HIV-1-suppressed patients : A feasible regimen in real life

enthalten in: International journal of STD & AIDS | 2018

von Lattuada, E. | Lanzafame, M. | Nicolè, S. | +4

5

HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities : results from the Sialon-II study

enthalten in: BMC infectious diseases | 2017

von Marcus, U. | Schink, S. | Sherriff, N. | +117

6

Socio-demographic Characteristics, Sexual and Test-Seeking Behaviours Amongst Men Who have Sex with Both Men and Women : Results from a Bio-behavioural Survey in 13 European Cities

enthalten in: AIDS and behavior | 2017

von Mirandola, M. | Gios, L. | Sherriff, N. | +110

7

Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL : a medium-term follow-up

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Lanzafame, M. | Nicolè, S. | Gibellini, D. | +6

8

Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient

enthalten in: International journal of STD & AIDS | 2017

von Lanzafame, M. | Lattuada, E. | Nicolè, S. | +4

9

Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient

enthalten in: International journal of STD & AIDS | 2017

von Lanzafame, M. | Lattuada, E. | Nicolè, S. | +4

10

Disseminated Mycobacterium avium complex disease in a patient with left ventricular assist device (Heart Mate II)

enthalten in: Le infezioni in medicina | 2015

von Cordioli, M. | Del Bravo, P. | Rigo, F. | +4